PROCTER & GAMBLE HEALTH L Peer Comparison
PGHL · Healthcare · Current price ₹6,799.5
Peers tracked
11
PROCTER & GAMBLE HEALTH L P/E
48.1x
Sector
Healthcare
PROCTER & GAMBLE HEALTH L vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,932.6 | 39.1x | 4,63,789 |
| DIVI S LABORATORIES LTD | ₹7,247.5 | 69.1x | 1,92,406 |
| TORRENT PHARMACEUTICALS L | ₹4,763 | 72.9x | 1,61,243 |
| ZYDUS LIFESCIENCES LTD | ₹1,143.7 | 22.0x | 1,15,087 |
| CIPLA LTD | ₹1,418.7 | 30.3x | 1,14,589 |
| LUPIN LIMITED | ₹2,443.2 | 20.6x | 1,11,704 |
| MANKIND PHARMA LIMITED | ₹2,484.2 | 53.7x | 1,02,569 |
| DR. REDDY S LABORATORIES | ₹1,211.2 | 26.8x | 1,01,090 |
| AUROBINDO PHARMA LTD | ₹1,533.4 | 25.9x | 89,061 |
| LAURUS LABS LIMITED | ₹1,529.8 | 92.8x | 82,511 |
| PROCTER & GAMBLE HEALTH L | ₹6,799.5 | 32.8x | 11,290 |
PROCTER & GAMBLE HEALTH L versus its peers
PROCTER & GAMBLE HEALTH L operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 48.1x may be cheap in one industry and expensive in another.
More on PROCTER & GAMBLE HEALTH L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.